Company / Interest Expense
Amphstar Pharmaceuticals, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$27.2M
FY2023
5-year range
$885.0K / $27.2M
FY2019-FY2023
Trend
+1371.2%
vs FY2022
Sector context
#17 of 44
Health Care
What the data says
Interest Expense changed +1371% YoY in FY2023, a notable deviation from the 7-year average annual change of +241%.
Based on SEC 10-K filings.
$27M in FY2023 with a 5-year CAGR of +156.8%.
Increased from $885,000 to $27M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +317.2%
- 5-Year CAGR
- +156.8%
- 10-Year CAGR
- -
Sector benchmark
#28 of 44 in Health CareTop 61% of 44This company $27.2M Sector average $291.0M
▼
-90.7% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s interest expense has grown for 4 consecutive years.
- 5-year CAGR of +156.8%, indicating consistent growth.
- In FY2023, interest expense increased 1371.2% year-over-year.
- Ranks #17 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $27.2M | +1371.2% |
| FY2022 | $1.8M | +108.6% |
| FY2021 | $885.0K | +136.6% |
| FY2020 | $374.0K | +214.3% |
| FY2019 | $119.0K | -51.0% |
| FY2018 | $243.0K | -70.6% |
| FY2017 | $826.0K | -19.3% |
| FY2016 | $1.0M | +3.7% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026